Baird Financial Group’s Medpace MEDP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$606K Buy
1,145
+505
+79% +$233K ﹤0.01% 1479
2026
Q1
$307K Sell
640
-9
-1% -$4.61K ﹤0.01% 1626
2025
Q4
$365K Buy
649
+3
+0.5% +$1.7K ﹤0.01% 1580
2025
Q3
$332K Sell
646
-698
-52% -$305K ﹤0.01% 1596
2025
Q2
$422K Buy
1,344
+181
+16% +$54.3K ﹤0.01% 1469
2025
Q1
$354K Sell
1,163
-22
-2% -$7.4K ﹤0.01% 1502
2024
Q4
$394K Sell
1,185
-11,698
-91% -$3.97M ﹤0.01% 1462
2024
Q3
$4.3M Buy
12,883
+2,504
+24% +$951K 0.01% 722
2024
Q2
$4.27M Buy
+10,379
New +$4.11M 0.01% 708

Other funds holding MEDP

Baird Financial Group's MEDP Position: Q2 2026 in Review

Baird Financial Group increased its Medpace (MEDP) stake by 79% in Q2 2026, buying an estimated $233K and bringing the position to 1,145 shares worth $606K. The position accounts for ﹤0.01% of the portfolio, ranked #1479.

Baird Financial Group first reported a position in MEDP in Q2 2024 and has held it in 9 quarters since. The position peaked at $4.3M in Q3 2024. 697 funds tracked by Wall St. Rank hold MEDP as of Q2 2026.

  • Baird Financial Group held 1,145 shares of Medpace worth $606K as of Q2 2026.
  • Baird Financial Group bought 505 Medpace shares in Q2 2026, an estimated $233K.
  • Medpace made up ﹤0.01% of Baird Financial Group's portfolio in Q2 2026, its #1479 holding.
  • Baird Financial Group first reported a position in Medpace in Q2 2024 and has held it in 9 quarters since.
  • Baird Financial Group's Medpace position peaked at $4.3M in Q3 2024.
  • 697 funds tracked by Wall St. Rank held Medpace as of Q2 2026.

Based on Baird Financial Group's 13F filing for Q2 2026, filed 12 Aug 2026.